Understanding Ketamine's Dissociative Effects (KD Study)
NCT04861051 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-04-22
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Conditions
Interventions
- DRUG
-
Study participants will receive 0.5mg/kg of ketamine - one single infusion
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Karl Deisseroth, MD, PhD · Stanford University
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-26
- Primary Completion
- 2028-08-01
- Completion
- 2028-08-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Long-term Treatment With the Ketogenic Diet in Epilepsy
NCT04646850 ·Status: ACTIVE_NOT_RECRUITING
-
Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury
NCT04933448 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04274179 ·Status: RECRUITING ·Phase: PHASE3
-
Ketogenic Diet Program for Epilepsy
NCT02497105 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet for Refractory Status Epilepticus
NCT01796574 ·Status: COMPLETED ·Phase: NA
-
Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation
NCT03347916 ·Status: UNKNOWN ·Phase: NA
-
Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
NCT03490487 ·Status: UNKNOWN ·Phase: PHASE4
-
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
NCT04613453 ·Status: TERMINATED ·Phase: PHASE2
-
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
NCT05591508 ·Status: UNKNOWN ·Phase: NA
-
Ketogenic Diet Drink Study
NCT03196271 ·Status: COMPLETED ·Phase: NA
-
The Effect of Carnitine Supplementation on Cardiac Function and Lipid Profile in Patients With Drug Resistant Epilepsy on Ketogenic Diet
NCT06198803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Diabetic Ketoacidosis and Its Impact on the Brain
NCT01753934 ·Status: COMPLETED
-
Ketogenic Diet in Infants With Epilepsy (KIWE)
NCT02205931 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Ketamine on the Length of Hospital Stay of Patients Hospitalized With Suicidal Ideation.
NCT02997722 ·Status: TERMINATED ·Phase: PHASE4
-
KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
NCT03779282 ·Status: COMPLETED
-
Evaluation of Keyo in Children With Epilepsy
NCT02915211 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of Strategies For Improving Ketogenic Diet Compliance
NCT05112107 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery
NCT01512355 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
NCT02318563 ·Status: WITHDRAWN ·Phase: PHASE3
-
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
NCT05756621 ·Status: RECRUITING
-
Ketamine and Glutamate After Brain Injury : a Microdialysis Study
NCT02232347 ·Status: UNKNOWN ·Phase: PHASE2
-
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754 ·Status: NOT_YET_RECRUITING
-
Ketogenic Diet for Child Epilepsy and Seizure Control
NCT00004729 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Quetiapine for Pediatric Delirium
NCT02056171 ·Status: TERMINATED ·Phase: PHASE1/PHASE2